Dr. Katja Weisel

Claim this profile

GSK Investigational Site

Studies Multiple Myeloma
Studies Relapse
7 reported clinical trials
11 drugs studied

Area of expertise

1Multiple Myeloma
Katja Weisel has run 7 trials for Multiple Myeloma. Some of their research focus areas include:
HBcAb positive
HBsAg negative
HBV DNA negative
2Relapse
Katja Weisel has run 1 trial for Relapse.

Clinical Trials Katja Weisel is currently running

More about Katja Weisel

Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Katja Weisel has experience with
  • Dexamethasone
  • Bortezomib
  • Belantamab Mafodotin
  • Pomalidomide
  • CC-92480
  • Daratumumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Katja Weisel specialize in?
Is Katja Weisel currently recruiting for clinical trials?
Are there any treatments that Katja Weisel has studied deeply?
What is the best way to schedule an appointment with Katja Weisel?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security